ERBB2 and ductal breast carcinoma in situ: In DCIS, several studies confirmed a similar phenotypic dependency of immune checkpoints and showed that the expression of PD-L1 and PD-1 on immune cells was significantly higher in the HER2-positive subtype [31,32,34,39].